Alternative Headline: Florida Boosts Cancer Screening
[MM Curator Summary]: Florida Medicaid’s financial incentive program boosted colorectal cancer screening rates by 4.4 points in under a year, impacting over 100,000 enrollees.
========================================
Key takeaways:
- A Florida initiative helped improve colorectal cancer screening by 4.4 percentage points among Medicaid enrollees.
- State had significant increases for individuals aged 45 to 55 years.
A Florida health initiative prompted a significant increase in colorectal cancer screening for eligible individuals with Medicaid within the state, demonstrating the strategy’s effectiveness and ability to target urgent public health needs.
Florida incentivized Medicaid managed care plans to focus on screening uptake with financial relief. The results included a 4.4 percentage-point increase in overall screening in less than a
Christopher R. Cogle
“The results were larger than expected,” Christopher R. Cogle, MD, professor of medicine at University of Florida and founding director of Florida Health Policy Leadership Academy, told Healio. “In just 9 months, we brought 100,000 Floridians up to speed for colorectal cancer screening, and for many of them, this was their first encounter with health care.”
“When large health systems try new interventions at the practice level, they might only get a few hundred patients up to speed with colorectal cancer screening,” he added. “Florida tried something new. It aimed for system-level change and found a scale of improvement that was larger than even the largest hospitals in the state.”
Financial relief for better uptake
Colorectal cancer incidence continues to rise in the U.S.
Nationally, a projected 154,270 cases will be diagnosed, and 52,900 people will die of the disease this year, according to American Cancer Society’s Cancer Statistics 2025 report. Only lung/bronchial cancer will cause more mortality among malignancy types.
Patients enrolled in Medicaid have “disproportionally and persistently low” screening rates compared with those with private insurance, researchers wrote.
“Coming out of COVID, we saw a cancer screening gap,” Cogle said.
Approximately 70% to 80% of individuals enrolled in Medicaid are covered through managed care, private insurance companies contracted to help manage costs, Cogle said.
“Today’s managed care plans agree to handle both the medical needs of patients as well as their health-related social needs,” he added.
At the same time, state agencies wield significant “leverage” with these agreements.
“Every Medicaid managed care plan has clear performance measures in their state contracts,” Cogle said. “These plans aren’t just processing claims. They’re competing on quality, because that’s what drives their payment.”
In 2022, Florida used a financial relief, called alleviation of liquidated damages, to try and improve screening for colorectal cancer.
“Florida Medicaid created a new financing approach. It offered relief on other performance measures if plans made an extra push to raise cancer screening rates within the next 9 months,” Cogle said.
Cogle and colleagues conducted a comparative effectiveness analysis of Florida Medicaid enrollees eligible for colorectal cancer screening before and after the initiative to determine its efficacy.
The pre-initiative cohort included 187,295 individuals (54.5% aged 56-65 years; 30.5% white; 19.9% Hispanic; 19.4% Black) and the post-initiative cohort had 191,659 (52.6% aged 56-65 years; 30.3% white; 22% Hispanic; 19.2% Black).
The proportion of Medicaid enrollees who had up-to-date screening for colorectal cancer at the end of the policy served as the primary endpoint.
‘Encouraging example’
After accounting for attrition, the post-initiative cohort had a significantly higher proportion of individuals up to date with colorectal cancer screening compared with the pre-initiative cohort (51.3% vs. 46.9%; P < .001).
Screening significantly increased among individuals aged 45 to 55 years (31.3% to 38.6%; P < .001) and those aged 56 to 65 years (56.6% to 60.8%; P < .001).
“This trend suggests that the 2021 United States Preventative Services Task Force guideline update, which lowered the recommended screening age from 50 to 45, was being adopted early by physicians and embraced by patients, even within a Medicaid population that often faces significant barriers to preventive care,” Cogle said. “It’s a rare and encouraging example of rapid uptake of national guidelines in a resource-constrained environment.”
Conversely, screening decreased significantly for those aged 66 to 75 years (62% to 56.7%; P < .001).
Investigations into barriers to screening for this population deserve future investigations, researchers wrote.
However, the program’s overall success underscores the importance of long-term initiatives.
“The next step is to make successful policies durable,” Cogle said. “We also need to share results widely, through publications, conferences, and other forums, and explore how federal guidance can help scale proven models nationwide.”
Cogle emphasized this approach could be used to improve outcomes in other areas.
“We’ve used similar state-level financial incentives in Florida, and they consistently prompt health plans to focus intensely, at least for a time, on urgent health needs,” he said. “Cancer has shown us a new way to improve population health. This was an experiment in a high-priority cancer, but the lessons translate to maternal health, birth outcomes, adolescent mental health, and more.”
“This is much bigger than oncology,” he added. “Medicaid isn’t just a safety net. It’s the country’s largest public health laboratory. When you align quality goals, financing, and private sector engagement, you can achieve large-scale results and learn from it.”
COLOR CODE:
General item, but important. Gets at main point of article= YELLOW
Has a dollar amount or number = GREEN
A specific topic that seems to be different than other topics = BLUE